Significantly, the gut microbiota community composition in mice receiving EcN and EcN-GLP-1 treatments showed significant similarity, while it differed markedly from the microbiota patterns in the control group, T1DM mice, and mice-treated with exenatide (Figure 3(d)). This evidence concerns the gene GLP1R and type 1 diabetes mellitus.